Trial
NCT02615938
Hydroxychloroquine (HCQ) in Pediatric Interstitial Lung Disease (ILD)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Matthias Griese
Collaborators
—
Condition
Interstitial Lung Disease
Intervention
Hydroxychloroquine sulfate
Why stopped
Lack of ressources after inspection and appropriate correcting actions to be taken
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-03